This inventor holds 31 USPTO granted patents and 2 EPO patents, primarily in Sulfonamide Compounds. Top assignees: Texas Biotechnology Corporation, Encysive Pharmaceuticals, Inc., Immunopharmaceutics, Inc.. Active years: 1995-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (1995 - 2002)
- Houston, TX (US) (1998 - 2004)
- Pearland, TX (US) (2003 - 2010)
Company Filing History:
21 out of 37 
7 out of 9 
2 out of 3 
Years Active: 1995-2010
Areas of Expertise:
Title: Chengde Wu: Innovating in Pharmaceutical Chemistry
Introduction
Chengde Wu, based in Pearland, TX, is a distinguished inventor with an impressive portfolio of 31 patents. His work primarily focuses on pharmaceutical chemistry, specifically targeting integrin binding inhibition and receptor antagonism. This article explores his latest patents, career highlights, and notable collaborations.
Latest Patents
Chengde Wu's recent patents showcase significant contributions to medical science. Notably, he developed carboxylic acid derivatives that inhibit the binding of integrins to their receptors. His innovations include methods for the inhibition of αβ-integrin binding to receptors, such as vascular cell adhesion molecule-1 (VCAM-1) and fibronectin, alongside compounds and formulations intended for controlling or preventing disease states. Additionally, he has worked on phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists, outlining their pharmaceutical applications and compositions.
Career Highlights
Throughout his career, Chengde has collaborated with various companies, including Texas Biotechnology Corporation and Encysive Pharmaceuticals, Inc., where he leveraged his expertise to pioneer advancements in pharmaceutical discoveries. He has significantly contributed to the landscape of drug development, enhancing therapeutic options in the industry.
Collaborations
Chengde Wu has partnered with notable colleagues, including Bore G Raju and Ming Fai Chan. These collaborations have not only fostered a productive research environment but have also led to innovative breakthroughs in the field of pharmaceuticals.
Conclusion
Chengde Wu's impressive body of work demonstrates his commitment to innovation within the realm of pharmaceutical chemistry. His patents not only reflect his expertise but also highlight the potential impact of his research on future medical treatments. As he continues to advance the field, his contributions will undoubtedly pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile